Susquehanna Fundamental Investments, LLC Grifols Sa Transaction History

Susquehanna Fundamental Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $334,899 - $411,115	-32,295 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $822,987 - $1.23 Million	-80,606 Reduced 71.4%	32,295 $363,000
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $569,159 - $699,819	40,452 Added 55.84%	112,901 $1.65 Million
Q2 2021 Aug 11, 2021	BUY	$16.62 - $18.94 $758,619 - $864,516	45,645 Added 170.29%	72,449 $1.26 Million
Q1 2021 May 17, 2021	SELL	$15.15 - $19.78 $869,140 - $1.13 Million	-57,369 Reduced 68.16%	26,804 $463,000
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $154,926 - $180,747	9,189 Added 12.25%	84,173 $1.55 Million
Q3 2020 Nov 16, 2020	BUY	$15.4 - $20.16 $1.15 Million - $1.51 Million	74,984 New	74,984 $1.3 Million
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $843,344 - $991,762	-46,236 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$16.28 - $25.63 $100,936 - $158,906	6,200 Added 15.49%	46,236 $931,000
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $794,714 - $911,219	40,036 New	40,036 $802,000

147

151M

2.38M

662K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.08B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.